Tuna tostadas and GLP-1 diets: what protein-first eating actually does

What's this video probably claiming?

Based on the caption and hashtags, @healthywithzamy is presenting tuna tostadas with aguachile sauce as an ideal meal for people on GLP-1 medications like semaglutide or tirzepatide. The framing, "siempre con la proteina por delante" (always lead with protein), suggests the creator is endorsing a protein-first eating strategy as particularly beneficial for GLP-1 users. The #LowFat and #GLP1Comida tags reinforce the idea that this meal fits the nutritional needs of people managing appetite suppression and reduced caloric intake on these drugs. The implicit claim seems to be that high-protein, low-fat meals like this one are the right way to eat when you're on a GLP-1 receptor agonist. That part is actually more defensible than most of what circulates in this space, but the details matter a lot.

What does the science actually show?

The protein-first recommendation for GLP-1 users has genuine clinical backing. GLP-1 receptor agonists cause significant reductions in overall food intake. A 2022 trial by Wilding et al. in the New England Journal of Medicine showed semaglutide 2.4 mg weekly produced roughly 15% body weight reduction, but lean mass loss was a documented side effect. When total calories drop sharply, protein adequacy becomes a real concern. Research by Cava et al. (2017, Advances in Nutrition) found that higher protein intake during caloric restriction helps preserve lean body mass better than standard protein intakes. Canned tuna is legitimately a high-protein, low-fat option: roughly 25 grams of protein per 100 grams with under 2 grams of fat. The aguachile sauce (lime, chili, cilantro) adds negligible calories. The meal structure here is reasonable. The question is whether one meal format translates into meaningful outcomes, and the evidence is more nuanced than a TikTok caption can carry.

Where does the social media noise diverge from clinical reality?

The problem isn't that this advice is wrong. It's that it's incomplete in ways that matter for people on actual medication. First, the #LowFat framing can mislead. Fat is not the enemy on GLP-1 therapy. Dietary fat slows gastric emptying, which may actually compound the delayed emptying already caused by these drugs, but omega-3 fats from fish are a net positive for cardiometabolic health, which is often why patients are on these medications to begin with. Second, the protein-first strategy is frequently presented on social media as a GLP-1 "hack" with almost magical muscle-preservation properties. Bray et al. (2012, JAMA) showed protein intake affects lean mass during caloric restriction, but the effect size is modest and context-dependent. Third, tostadas introduce refined carbohydrate and sodium that may matter for patients with type 2 diabetes using these drugs therapeutically. That context disappears entirely in the caption.

What should you actually know?

If you're on semaglutide, tirzepatide, or another GLP-1 receptor agonist and your appetite is significantly suppressed, getting enough protein per day is a legitimate priority. Current guidance from clinical nutrition researchers generally suggests 1.2 to 1.6 grams of protein per kilogram of body weight during active weight loss to support muscle retention, though your prescribing clinician should guide your specific targets. Meals like the one in this video can fit that goal. But no single recipe solves the complexity of eating well on these medications. Nausea, early satiety, and changes in food preferences are real barriers. A 2023 analysis by Jastreboff et al. in the New England Journal of Medicine on tirzepatide noted that dietary counseling alongside medication produced better outcomes than medication alone. Social media meal content is not dietary counseling. If you're using GLP-1 therapy, work with a registered dietitian who understands the pharmacology, not just the hashtags.